saaf

BMY

BRISTOL MYERS SQUIBB CO

Non-compliant
Sector
Healthcare
Industry
Drug Manufacturers - General
Score
0/100
Data as of
2026-02-11
Figures are read automatically from SEC filings — tap any number to verify the source.
How is this score computed?

Non-compliant and needs-review verdicts always score 0, regardless of any ratio — so nothing built on top of this engine treats them as safe by default.

Price

Screening standard

How the verdict was computed

  • Business activity

    Business activity is compliant.

  • Debt vs. market cap40.27% vs limit 33.00%

    interest-bearing debt / market cap = 40.27% (≥ 33% limit).

  • Interest income vs. revenue1.22% vs limit 5.00%

    interest income / total revenue = 1.22% (< 5% limit).

  • Cash & interest-bearing assets vs. market cap9.29% vs limit 33.00%

    (cash + interest-bearing securities) / market cap = 9.29% (< 33% limit).

Every number, sourced

Figures read directly from SEC EDGAR XBRL facts. Don't trust us — verify.

FigureValue (as filed)FilingSource
Total revenueRevenues$48.2B10-K · 2026-02-11View filing ↗
Interest-bearing debtLong term debt$44.8B10-K · 2026-02-11View filing ↗
Cash & interest-bearing securities· 3 components$10.3B10-K · 2026-02-11View filing ↗
Cash and cash equivalents at carrying value$10.2B
Marketable securities current$130.0M
Marketable securities noncurrent$0
Interest incomeInvestment income interest$586.0M10-K · 2026-02-11View filing ↗
Total assetsAssets$90.0B10-K · 2026-02-11View filing ↗
ReceivablesAccounts receivable net current$9.6B10-K · 2026-02-11View filing ↗
Shares outstandingEntity common stock shares outstanding2.0B shares10-Q · 2026-04-30View filing ↗
Priceyahoo:24mo-trailing-avg$54.506market

Values & Controversies

Separate from the shariah verdict above — always.

No flags. This company isn't on the BNC (Boycott National Committee) priority or divestment lists, or any grassroots BDS-supported campaign we track.